Search Results
Dr. Crew on Updated Data With Margetuximab in HER2+ Breast Cancer
Margetuximab for the treatment of HER2-positive breast cancer
Dr. Crew on the APHINITY Trial Results in HER2+ Breast Cancer
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Mahtani & Dr. Schwartzberg
Dr. Rugo on the Phase III SOPHIA Trial in HER2+ Breast Cancer
SOPHIA Trial in R/R HER2+ mBC
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Irene and Dr. Vogel
2022 KU Post San Antonio Review | Metastatic HER2 Positive Breast Cancer: Novel Treatment Approaches
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Traina & Dr. Carey
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Bagegni & Dr. Gradishar
New & Supporting Data for Optimizing Therapy in HER2+ Breast Cancer | Dr. Kaklamani and Dr. O’Regan
HER2 Positive Breast Cancer: What's New in Treatment and Research at MBC Patient Forum 2019
